Fennec Pharmaceuticals Stock Today
FENC Stock | USD 9.34 0.23 2.40% |
Performance0 of 100
| Odds Of DistressOver 84
|
Fennec Pharmaceuticals is trading at 9.34 as of the 19th of April 2024, a -2.4 percent decrease since the beginning of the trading day. The stock's open price was 9.57. Fennec Pharmaceuticals has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Fennec Pharmaceuticals are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of June 2001 | Category Healthcare | Classification Health Care |
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina. Fennec Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 27.1 M outstanding shares of which 1.81 M shares are currently shorted by private and institutional investors with about 11.17 trading days to cover. More on Fennec Pharmaceuticals
Moving against Fennec Stock
0.55 | PBYI | Puma Biotechnology Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 9th of May 2024
Fennec Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Fennec Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Fennec Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, Director | Rostislav Raykov | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation Analysts covering Fennec Pharmaceuticals report their recommendations after researching Fennec Pharmaceuticals' financial statements, talking to executives and customers, or listening in on Fennec Pharmaceuticals' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Fennec Pharmaceuticals. The Fennec consensus assessment is calculated by taking the average forecast from all of the analysts covering Fennec Pharmaceuticals. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength Based on the key indicators related to Fennec Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Fennec Pharmaceuticals may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Fennec Pharmaceuticals is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fennec Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Fennec Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Fennec Pharmaceuticals' financial leverage. It provides some insight into what part of Fennec Pharmaceuticals' total assets is financed by creditors.
|
Fennec Pharmaceuticals (FENC) is traded on NASDAQ Exchange in USA. It is located in 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709 and employs 29 people. Fennec Pharmaceuticals is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 266.4 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fennec Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Fennec Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Fennec Pharmaceuticals conducts business under Biotechnology sector and is part of Health Care industry. The entity has 27.1 M outstanding shares of which 1.81 M shares are currently shorted by private and institutional investors with about 11.17 trading days to cover.
Fennec Pharmaceuticals currently holds about 14.91 M in cash with (17.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.57.
Check Fennec Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationFennec Pharmaceuticals retains a total of 27.1 Million outstanding shares. Over half of Fennec Pharmaceuticals' outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Fennec Pharmaceuticals. Please watch out for any change in the institutional holdings of Fennec Pharmaceuticals as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Fennec Ownership Details
Fennec Stock Price Odds Analysis
What are Fennec Pharmaceuticals' target price odds to finish over the current price? Based on a normal probability distribution, the odds of Fennec Pharmaceuticals jumping above the current price in 90 days from now is about 87.62%. The Fennec Pharmaceuticals probability density function shows the probability of Fennec Pharmaceuticals stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.2738. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Fennec Pharmaceuticals will likely underperform. Additionally, fennec Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Fennec Pharmaceuticals to move above the current price in 90 days from now is about 87.62 (This Fennec Pharmaceuticals probability density function shows the probability of Fennec Stock to fall within a particular range of prices over 90 days) .
Fennec Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Fennec Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Fennec Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Fennec Pharmaceuticals' value.Instituion | Recorded On | Shares | |
Geode Capital Management, Llc | 2023-12-31 | 218.6 K | |
Worth Venture Partners, Llc | 2023-12-31 | 141.5 K | |
683 Capital Management Llc | 2023-12-31 | 140 K | |
Northern Trust Corp | 2023-12-31 | 111.8 K | |
Lion Point Capital, Lp | 2023-12-31 | 110 K | |
Morgan Stanley - Brokerage Accounts | 2023-12-31 | 77.1 K | |
Cibc World Markets Inc. | 2023-12-31 | 72 K | |
Eam Investors, Llc | 2023-12-31 | 65.8 K | |
Goldman Sachs Group Inc | 2023-12-31 | 62 K | |
Southpoint Capital Advisors Lp | 2023-12-31 | 4.1 M | |
Sonic Gp Llc | 2023-12-31 | 2.4 M |
Fennec Pharmaceuticals Historical Income Statement
Fennec Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Fennec's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Fennec Pharmaceuticals revenue and expense. Fennec Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Fennec Pharmaceuticals' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 21.6 M, whereas Operating Income is forecasted to decline to (13.7 M). View More FundamentalsFennec Stock Against Markets
Picking the right benchmark for Fennec Pharmaceuticals stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Fennec Pharmaceuticals stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Fennec Pharmaceuticals is critical whether you are bullish or bearish towards Fennec Pharmaceuticals at a given time. Please also check how Fennec Pharmaceuticals' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fennec Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
All Next | Launch Module |
Fennec Pharmaceuticals Corporate Directors
Fennec Pharmaceuticals corporate directors refer to members of a Fennec Pharmaceuticals board of directors. The board of directors generally takes responsibility for the Fennec Pharmaceuticals' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Fennec Pharmaceuticals' board members must vote for the resolution. The Fennec Pharmaceuticals board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Chris Rallis | Independent Director | Profile | |
Marco Brughera | Director | Profile | |
Adrian Haigh | Independent Director | Profile | |
Steven Skolsky | Independent Director | Profile |
How to buy Fennec Stock?
Before investing in Fennec Pharmaceuticals, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Fennec Pharmaceuticals. To buy Fennec Pharmaceuticals stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Fennec Pharmaceuticals. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Fennec Pharmaceuticals stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Fennec Pharmaceuticals stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Fennec Pharmaceuticals stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Fennec Pharmaceuticals, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Fennec Stock please use our How to Invest in Fennec Pharmaceuticals guide.
Already Invested in Fennec Pharmaceuticals?
The danger of trading Fennec Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Fennec Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Fennec Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Fennec Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Fennec Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fennec Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fennec Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fennec Pharmaceuticals Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Revenue Per Share 0.8 | Quarterly Revenue Growth 5.342 | Return On Assets (0.30) | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.